Last updated on June 2018

Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention

Brief description of study

This study will test PANO in combination with tacrolimus/sirolimus (TAC/SIR) for acute GVHD prevention. The purpose of this study is to determine if Panobinostat (PANO) when used in combination with sirolimus and tacrolimus will help reduce the incidence of Graft-vs-host disease (GVHD).

Clinical Study Identifier: NCT02588339

Contact Investigators or Research Sites near you

Start Over

Lia Perez, M.D.

H. Lee Moffitt Cancer Center and Research Institute
Tampa, FL United States
  Connect »